Using Paneth cell characteristics to predict outcomes in ulcerative colitis

Paneth cell phenotype as a predictive biomarker for ulcerative colitis

NIH-funded research Washington University · NIH-10682400

This study is looking at how certain cells in the intestine can help doctors predict how well patients with ulcerative colitis will do after surgery, with the goal of creating better, more tailored treatment plans for them.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University NIH-funded
Lab location1 site (Saint Louis, United States)
Project IDNIH-10682400 on NIH RePORTER

What this research studies

This research investigates how the characteristics of Paneth cells, which are specialized cells in the intestine, can be used to predict the outcomes for patients with ulcerative colitis (UC). The study aims to determine if the appearance of these cells at the time of surgery can forecast complications after procedures like total colectomy and ileal pouch anal anastomosis. By employing advanced techniques, including deep learning, the researchers hope to improve the accuracy and consistency of their analyses. This could lead to more personalized treatment strategies for patients suffering from UC.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients diagnosed with ulcerative colitis who are scheduled for surgical procedures such as total colectomy.

Not a fit: Patients with ulcerative colitis who are not undergoing surgery or those with other unrelated gastrointestinal conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide a reliable biomarker to help tailor treatment plans for patients with ulcerative colitis, potentially improving their outcomes.

How similar studies have performed: Previous research has shown that Paneth cell characteristics can predict outcomes in Crohn's disease, suggesting a potential for success in similar applications for ulcerative colitis.

Where this research is happening

Saint Louis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.